Detalles de la búsqueda
1.
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
Lancet Oncol
; 19(2): 229-239, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29361469
2.
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 65(8): e27077, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693796
3.
Clinical trial enrollment of adolescents and young adults with sarcoma.
Cancer
; 123(18): 3434-3440, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28493547
4.
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors.
Pediatr Blood Cancer
; 59(5): 865-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22847981
5.
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
Clin Cancer Res
; 28(11): 2221-2228, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101885
6.
Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin.
Blood
; 113(26): 6691-4, 2009 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19411627
7.
Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung Cancer.
Ther Innov Regul Sci
; 54(5): 1208-1214, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32865803
8.
Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors.
J Oncol Pract
; 15(12): e1050-e1065, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31647695
9.
Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
Pediatr Blood Cancer
; 50(4): 779-83, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17635000
10.
Challenges in Opening and Enrolling Patients in Clinical Trials.
Am Soc Clin Oncol Educ Book
; 37: 139-143, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28561725
11.
Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.
Clin Cancer Res
; 23(1): 9-12, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27780857
12.
FDA Approval Summary: Eribulin for Patients with Unresectable or Metastatic Liposarcoma Who Have Received a Prior Anthracycline-Containing Regimen.
Clin Cancer Res
; 23(21): 6384-6389, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28242632
13.
FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma.
Clin Cancer Res
; 23(19): 5666-5670, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28235882
14.
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab.
Clin Cancer Res
; 23(14): 3484-3488, 2017 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087644
15.
Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials.
J Natl Cancer Inst
; 113(5): 507-508, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32857840
16.
Expansion Cohorts in First-in-Human Solid Tumor Oncology Trials.
Clin Cancer Res
; 21(20): 4545-51, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26473190
17.
18.
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Clin Cancer Res
; 19(15): 4239-48, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23766359
19.
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.
Cancer Chemother Pharmacol
; 67(6): 1291-7, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20725726
20.
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.
J Clin Oncol
; 28(35): 5174-81, 2010 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21060028
Resultados
1 -
20
de 20
1
Próxima >
>>